Multicentre, single-blind randomised controlled trial comparing MyndMove neuromodulation therapy with conventional therapy in traumatic spinal cord injury: a protocol study
Abstract
This protocol is describing a multicentre, single-blind randomised controlled trial. The objective is to compare the efficacy of MyndMove therapy versus conventional therapy (CT) in improving upper extremity function in individuals with C4–C7 traumatic, incomplete spinal cord injury (SCI). It is being conducted in two US and two Canadian SCI rehabilitation centres.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Sep 01, 2020
- Source ID
- 10.1136/bmjopen-2020-039650
Entities
People
- Daria O'reilly
- Jacqueline Pierce
- James M Bowen
- James R. Wilson
- Kim D Anderson
- Kristin E Musselman
- Lehana Thabane
- Milos R Popovic
- Naaz Kapadia
- Radha Korupolu
Organizations
- United States Department of Defense